SAE3 Antibody

What is SAE3 and what is its biological function?

SAE3 (also known as ASK3) is a reported synonym of the MAP3K15 gene, which encodes mitogen-activated protein kinase kinase kinase 15. This protein functions primarily in protein phosphorylation pathways and other cellular signaling processes. In humans, canonical SAE3 protein consists of 1313 amino acid residues with a molecular mass of approximately 147.4 kilodaltons, though researchers have identified three distinct isoforms. SAE3 belongs to the STE Ser/Thr protein kinase family .

Research in yeast models has demonstrated that SAE3 plays a critical role in meiotic recombination, particularly through its interaction with Mei5 and involvement in the assembly of Rad51 and Dmc1 recombinases. The YNEL amino acid sequence in SAE3 has been identified as especially important for proper meiotic function .

What applications are SAE3 antibodies most commonly used for?

SAE3 antibodies are versatile research tools employed in several experimental applications:

• Western Blotting (WB): For detecting and quantifying SAE3 protein in cell or tissue lysates

• Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative measurement of SAE3 in solution

• Flow Cytometry (FCM): For analyzing SAE3 expression in individual cells

• Immunohistochemistry (IHC): For visualizing SAE3 distribution in tissue sections

These applications allow researchers to investigate SAE3 expression, localization, and function across diverse biological contexts and experimental systems.

What criteria should guide the selection of a SAE3 antibody for specific research applications?

When selecting a SAE3 antibody, researchers should consider several critical factors:

• Application compatibility: Verify the antibody has been validated for your intended application (WB, ELISA, IHC, etc.)

• Species reactivity: Confirm the antibody recognizes SAE3 in your species of interest (human, mouse, etc.)

• Epitope specificity: Consider which region of SAE3 the antibody targets, particularly when studying specific isoforms

• Antibody format: Determine whether monoclonal (higher specificity) or polyclonal (potentially higher sensitivity) antibodies are more appropriate for your experimental design

• Validation data: Review existing literature and manufacturer data demonstrating antibody specificity and performance

For advanced studies examining mutant forms of SAE3 or specific post-translational modifications, epitope selection becomes especially critical as mutations in conserved residues can significantly impact antibody recognition .

How do mutations in conserved amino acid residues affect SAE3 function and antibody detection?

Research on yeast Sae3 has revealed that specific conserved amino acid residues, particularly the YNEL sequence (Y56, N57, E58, and L59), are critical for SAE3 function in meiotic recombination. Each residue contributes uniquely to protein function:

These findings have significant implications for antibody-based detection. Antibodies targeting regions containing these critical residues may show diminished binding to mutant forms of SAE3. The E58A mutation particularly affects protein stability, resulting in lower abundance of the mutant protein . Researchers studying SAE3 mutations should consider using multiple antibodies targeting different epitopes to ensure comprehensive detection.

What computational and experimental approaches can enhance SAE3 antibody specificity?

Developing highly specific SAE3 antibodies, particularly for distinguishing between similar epitopes or post-translational modifications, requires sophisticated approaches:

• Computational modeling can identify different binding modes associated with particular epitopes. Models that disentangle binding modes can guide the design of antibodies with customized specificity profiles, even when targeting chemically similar ligands .

• Phage display selection with systematic variation of complementary determining regions (CDRs) can efficiently screen antibody libraries. In particular, focusing on four consecutive positions of the third complementary determining region (CDR3) can generate libraries with diverse binding properties while remaining small enough for comprehensive analysis .

• Energy function optimization can generate novel antibody sequences with predefined binding profiles. This approach allows the design of either:

  • Cross-specific antibodies that interact with several distinct ligands

  • Highly specific antibodies that interact with a single target while excluding others

These methodologies enable researchers to design SAE3 antibodies with precise specificity profiles beyond what can be achieved through standard selection methods alone.

How can researchers validate SAE3 antibody specificity in complex biological samples?

Rigorous validation of SAE3 antibody specificity is essential for reliable experimental outcomes. Researchers should implement multiple complementary approaches:

• Genetic validation: Use SAE3 knockout/knockdown samples as negative controls to confirm signal specificity.

• Peptide competition assays: Pre-incubate the antibody with immunizing peptide before application to samples. Specific antibody signals should be abolished by this competition.

• Multiple antibody validation: Use several antibodies targeting different SAE3 epitopes and compare detection patterns.

• Immunoprecipitation followed by mass spectrometry: Verify that SAE3 is the predominant protein pulled down by the antibody.

• Correlation of protein and mRNA expression: Compare antibody-detected protein levels with mRNA expression measured by qPCR or RNA-seq.

The study of Sae3-Flag mutants demonstrates the importance of validation. Researchers confirmed that Sae3-Flag-L59A protein could not interact with Mei5 in immunoprecipitation experiments, validating the critical role of L59 in complex formation . Similar approaches can verify antibody specificity and function in various experimental contexts.

What protocol optimizations improve SAE3 detection in western blotting?

Optimizing western blotting protocols for SAE3 detection requires attention to several technical considerations:

Sample Preparation:

• Use fresh samples with protease inhibitors to prevent degradation.

• For large proteins like SAE3 (147.4 kDa), use lower percentage (6-8%) SDS-PAGE gels for better resolution.

• Include positive controls (tissues/cells known to express SAE3) and negative controls.

Blotting Protocol:

• Transfer: Use wet transfer at low voltage (30V) overnight for efficient transfer of large proteins.

• Blocking: Use 5% non-fat dry milk or BSA in TBST for 1-2 hours at room temperature.

• Primary antibody: Dilute according to manufacturer recommendations (typically 1:500-1:2000) and incubate overnight at 4°C.

• Washing: Perform 4-5 washes with TBST, 10 minutes each.

• Secondary antibody: Use appropriate HRP-conjugated antibody (typically 1:5000-1:10000) for 1 hour at room temperature.

• Detection: Use enhanced chemiluminescence and optimize exposure time.

Troubleshooting:

• No signal: Increase antibody concentration, extend incubation time, verify transfer efficiency.

• Multiple bands: Test specificity with peptide competition, optimize antibody dilution.

• High background: Increase washing steps, decrease antibody concentration, use fresher blocking reagents.

When detecting specific SAE3 mutants, researchers should be aware that mutations can affect expression levels, as demonstrated with the E58A mutation that reduces protein stability .

How can immunoprecipitation with SAE3 antibodies reveal protein interaction networks?

Immunoprecipitation (IP) with SAE3 antibodies is a powerful approach for investigating protein-protein interactions:

Recommended Protocol:

• Cell lysis: Use non-denaturing buffer containing protease inhibitors (e.g., 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40 or Triton X-100).

• Pre-clearing: Incubate lysate with protein A/G beads to remove non-specific binders.

• Antibody binding: Add SAE3 antibody (2-5 μg per mg of protein lysate) and incubate overnight at 4°C with gentle rotation.

• Bead capture: Add protein A/G beads and incubate for 2-4 hours at 4°C.

• Washing: Wash beads 3-5 times with lysis buffer.

• Elution: Elute bound proteins with SDS sample buffer or mild elution buffer.

• Analysis: Analyze by western blotting or mass spectrometry.

This approach has been successfully employed to study the Mei5-Sae3 interaction. Researchers demonstrated that wild-type Sae3-Flag and mutants Y56A and N57A could be co-immunoprecipitated with Mei5, while the L59A mutant could not, revealing the critical role of L59 in complex formation .

For comprehensive interaction studies, combining IP with mass spectrometry can identify novel SAE3 interaction partners under different experimental conditions, providing insights into SAE3's role in various cellular processes.

What techniques provide quantitative measurement of SAE3 levels in biological samples?

Several techniques enable quantitative assessment of SAE3 levels:

• Enzyme-Linked Immunosorbent Assay (ELISA):

  • Sandwich ELISA: Two antibodies recognizing different SAE3 epitopes provide high specificity

  • Competitive ELISA: Sample SAE3 competes with standard SAE3 for antibody binding

  • Advantages: High sensitivity, good for high-throughput screening

• Western Blotting with Densitometry:

  • Use standard curve with recombinant SAE3 for absolute quantification

  • Advantages: Distinguishes different isoforms or modified forms

• Quantitative Immunofluorescence:

  • Measure fluorescence intensity in fixed cells or tissues stained with SAE3 antibodies

  • Advantages: Provides spatial information and single-cell resolution

• Flow Cytometry:

  • For cellular samples, use permeabilization followed by SAE3 antibody staining

  • Measure mean fluorescence intensity as relative abundance measure

  • Advantages: High-throughput, single-cell analysis, statistical power

• Mass Spectrometry:

  • Use methods like multiple reaction monitoring (MRM) with isotopically labeled standards

  • Advantages: High specificity, can simultaneously measure multiple proteins

Each method offers distinct advantages, and selection should be guided by research questions, sample availability, and required sensitivity/specificity.

How can SAE3 antibodies elucidate the role of SAE3 in meiotic recombination?

SAE3 plays a critical role in meiotic recombination, and antibodies provide powerful tools for investigating its function:

• Immunolocalization Studies:

  • Visualize SAE3 foci on meiotic chromosome spreads using fluorescence microscopy

  • Co-stain with recombination proteins (Rad51, Dmc1, Mei5) to analyze co-localization patterns

  • Track temporal dynamics during meiotic progression

  • Compare wild-type and mutant cells to understand the impact of specific residues

• Protein Complex Analysis:

  • Use immunoprecipitation with SAE3 antibodies to identify and characterize protein complexes

  • Western blotting of IP fractions can confirm interactions with known partners like Mei5

  • Mass spectrometry can identify novel interaction partners

• Functional Analysis:

  • Track the formation and resolution of recombination intermediates in wild-type versus SAE3-mutant cells

  • Analyze how specific mutations (Y56A, N57A, E58A, L59A) affect complex formation and recombination progression

  • Investigate how these mutations impact the assembly of Rad51 and Dmc1 recombinases

Research using these approaches has revealed that SAE3 is essential for Dmc1 assembly and proper meiotic progression, with specific amino acid residues (particularly the YNEL sequence) playing distinct and critical roles .

What insights can SAE3 antibodies provide about protein kinase activity and signaling pathways?

As a member of the STE Ser/Thr protein kinase family involved in protein phosphorylation , SAE3/ASK3/MAP3K15 likely participates in important signaling pathways. SAE3 antibodies can reveal:

• Pathway Activation Dynamics:

  • Use phospho-specific antibodies to monitor SAE3 activation states

  • Track SAE3 phosphorylation in response to various stimuli

  • Map upstream activators and downstream effectors in signaling cascades

• Subcellular Localization Changes:

  • Use immunofluorescence to visualize SAE3 translocation in response to stimuli

  • Correlate localization changes with activation states and interaction partners

• Protein Complex Dynamics:

  • Use immunoprecipitation to identify dynamic changes in SAE3 complexes during signaling

  • Compare complexes formed under different cellular conditions

  • Identify scaffold proteins that might organize SAE3-containing signaling hubs

• Cross-talk Between Pathways:

  • Investigate how SAE3 might integrate signals from multiple pathways

  • Study how SAE3 inhibition or activation affects other signaling components

These approaches can establish comprehensive models of SAE3's role in cellular signaling networks and potential contributions to disease mechanisms.

What are common challenges when using SAE3 antibodies and how can they be addressed?

Researchers working with SAE3 antibodies may encounter several challenges:

• Non-specific Binding:

  • Problem: Antibody recognizes proteins other than SAE3

  • Solutions:

    • Increase blocking concentration (5-10% BSA or milk)

    • Optimize antibody dilution through titration

    • Use more stringent washing conditions

    • Validate specificity with peptide competition or genetic controls

• Weak Signal:

  • Problem: Low-intensity detection of SAE3

  • Solutions:

    • Increase antibody concentration or incubation time

    • Use signal amplification methods

    • Enrich for SAE3 through immunoprecipitation before detection

    • Verify SAE3 expression in your sample type

• Detecting Specific Isoforms:

  • Problem: Difficulty distinguishing between the three known isoforms of SAE3

  • Solutions:

    • Use isoform-specific antibodies targeting unique regions

    • Run higher resolution gels to separate isoforms by size

    • Combine with RT-PCR to correlate protein detection with isoform-specific mRNA expression

• Detecting Mutant Forms:

  • Problem: Reduced detection of mutant SAE3, as seen with stability issues in E58A mutation

  • Solutions:

    • Use antibodies targeting regions away from the mutation

    • Employ multiple antibodies targeting different epitopes

    • Adjust protocols to account for potentially lower expression levels

Addressing these challenges requires systematic optimization and thorough validation to ensure reliable results when working with SAE3 antibodies.

How can researchers reconcile discrepancies between SAE3 protein and mRNA expression data?

Discrepancies between SAE3 protein levels (detected with antibodies) and mRNA expression may arise from biological or technical factors:

Biological Factors:

• Post-transcriptional Regulation:

  • SAE3 mRNA may be regulated by microRNAs or RNA-binding proteins

  • Solution: Analyze miRNA expression or perform RNA immunoprecipitation studies

• Protein Stability Differences:

  • Mutations like E58A can affect SAE3 protein stability without affecting transcription

  • Solution: Perform protein half-life studies with cycloheximide chase experiments

• Translational Efficiency:

  • Translation of SAE3 mRNA may be regulated independently of transcription

  • Solution: Analyze polysome fractions to assess translation efficiency

Technical Factors:

• Antibody Recognition Limitations:

  • Antibodies may not detect all isoforms or modified forms of SAE3

  • Solution: Use multiple antibodies targeting different epitopes

• Method Sensitivity Differences:

  • Protein and mRNA detection methods have different sensitivity thresholds

  • Solution: Use appropriate controls and standards for both measurements

• Sample Preparation Effects:

  • Protein degradation during sample preparation may affect antibody detection

  • Solution: Standardize sample collection and processing protocols

Understanding these factors can provide insights into the regulatory mechanisms controlling SAE3 expression and function, potentially revealing novel aspects of SAE3 biology.